Henry Schein, Inc.

Henry Schein, Inc.

82.94
USD
-2.02
(-2.38%)
3.84EPS
22.79P/E
9.28BMarket Cap
Mar 02Next Earn
Henry Schein, Inc.
NASDAQ:HSIC
(Nasdaq Stock Market)

Recent

price

82.94

P/E

ratio

22.79

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
USD
41.77
47.33
51.09
55.63
61.54
64.16
71.59
56.66
61.69
67.56
71.01
88.52
92.95
94.47
99.95
109.13
120.2
Revenue per Share
1.81
2.04
2.22
2.51
2.77
2.89
3.14
2.59
3.51
4.7
2.83
4.5
3.95
3.18
3.08
3.29
3.68
Basic EPS, GAAP
1.98
2.83
2.04
3.51
3.03
3.28
3.54
3.08
4.02
3.91
3.86
4.5
3.72
2.7
5.52
4.74
4.89
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
13.12
13.52
14.88
16.26
16.75
17.5
17.59
18.29
19.56
20.91
23.5
24.97
26.15
28.28
27.33
28.03
28.58
Book Value per Share
3.16
2.9
3.11
4.26
1.68
2.31
0.95
-1.05
3.33
-0.26
2.56
-0.71
-0.26
-8.79
-12.22
-17.15
-18.38
Tangible Book Value per Share
180
180
175
172
169
166
162
157
153
148
143
140
136
131
127
121
114
Basic Weighted Avg Shares
7,527
8,530
8,940
9,561
10,371
10,630
11,572
8,883
9,418
9,986
10,119
12,401
12,647
12,339
12,673
13,184
13,734
Sales/Revenue/Turnover
7.09
6.82
7.09
7.08
6.9
7.23
7.06
7.6
7.36
7.34
5.61
6.93
6.94
5.63
5.77
5.75
5.79
Operating Margin (%)
101
116
125
128
152
159
170
134
144
185
186
210
194
222
268
281
303
Depreciation Expense
326
368
388
432
466
479
507
406
536
695
404
631
538
416
390
398
421
Net Income, GAAP
31.88
31.65
31.09
28.72
30.4
29.33
28.84
49.06
20.01
23.45
19.08
23.83
23.58
22.14
24.95
23.64
24.31
Effective Tax Rate (%)
4.33
4.31
4.34
4.51
4.49
4.51
4.38
4.57
5.69
6.96
3.99
5.09
4.25
3.37
3.08
3.02
3.07
Profit Margin (%)
1,001
1,001
1,232
1,284
1,133
1,084
1,022
1,257
956
1,188
1,508
1,537
1,764
1,805
1,180
1,236
1,178
Working Capital
395
364
488
450
543
464
715
908
980
799
755
1,079
1,315
2,247
2,089
2,561
2,670
LT Debt
2,717
2,836
3,051
3,286
3,381
3,429
3,408
3,657
3,854
3,917
4,312
4,676
4,671
5,153
4,837
4,794
4,731
Total Equity
11.94
12.09
12.23
12.91
12.41
12.2
12.19
6.73
8.46
10.07
8.34
11.46
9.36
6.75
5.93
6.2
6.26
Return on Invested Capital (%)
11.18
10.92
10.9
11.18
11.25
10.85
10.82
7.62
10.26
13.24
8.24
11.11
8.9
6.6
6.16
6.17
6.16
Return on Capital (%)
14.25
15.18
15.38
15.99
16.65
16.82
17.85
14.5
18.57
23.32
12.73
18.63
15.66
11.72
11.07
11.99
12.91
Return on Common Equity (%)

Capital Structure

USD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
1,159
1,238
1,221
LT Borrowings
2,327
2,300
2,382
LT Finance Leases
263
275
288
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
114
112
111
Market Capitalization
8,433
9,347
9,282

Working Capital

USD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
4,496
4,600
4,776
Cash, Cash Equivalents & STI
138
157
184
Accounts Receivable, Net
1,719
1,763
1,875
Inventories
2,014
2,059
2,050
Total Current Liabilities
3,297
3,488
3,598
Payables & Accruals
2,138
2,250
2,377
ST Debt
1,159
1,238
1,221
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
3.54%
2.33%
-0.89%
Free Cash Flow
5.08%
8.96%
-18.14%
Net Income, GAAP
2.03%
2.93%
2.05%
Sales/Revenue/Turnover
2.78%
5.77%
4.03%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
3,172
3,136
3,174
3,191
12,673
2025
3,168
3,240
3,339
3,437
13,184
2026
3,368
3,458
3,471
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.72
0.81
0.78
0.75
3.08
2025
0.89
0.71
0.84
0.86
3.29
2026
0.93
0.83
1.07
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Henry Schein, Inc. (Nasdaq: HSIC) provides health care products and services to office-based dental, medical, and animal health practitioners worldwide through its global distribution network. Founded in 1932 and headquartered in Melville, New York, the company distributes more than 300,000 branded and private-label products from over 300 distribution centers across 33 countries and territories; its offerings span dental consumables, equipment, and digital technologies including practice management software such as Dentrix Ascend; medical supplies, pharmaceuticals, diagnostics, and equipment for physician practices, ambulatory surgery centers, and alternate care sites; technology and value-added services encompassing electronic health records, financial services, consulting, and education; as well as global specialty products like dental implants, biomaterials, endodontic, orthodontic, and orthopedic items. Henry Schein serves over 1 million customers, including general dentists, specialists, dental laboratories, veterinary practices, and institutional health care providers, with 2024 sales reaching $12.7 billion. In recent developments, the company expanded its strategic partnership with KKR & Co. in November 2025, amending the agreement to allow KKR to increase its ownership stake up to 19.9% through open-market purchases while targeting over $200 million in operating income improvements; it broadened collaboration with vVARDIS in late 2025, securing exclusive U.S. distribution rights for the drill-free Curodont Fluor Plus product effective January 2026 across general dentistry, orthodontics, and pediatric sectors; Henry Schein also completed acquisitions of medical suppliers including Prism Medical Products in 2021, Shield Healthcare and Mini Pharmacy in 2023, and Acentus in late 2024 to bolster its homecare medical supplies market presence; additionally, it reported record third-quarter 2025 results with raised full-year guidance, including 3%-4% sales growth and mid-single-digit adjusted EBITDA expansion, alongside a $229 million share repurchase program.

Company News

  • Henry Schein, Inc. (HSIC) Presents at Jefferies Global Healthcare Conference 2026 Transcript

  • Henry Schein Updates Presentation of Non-GAAP Financial Measures

  • CareQuest and Henry Schein Launch the BRIDGE Health Network to Advance Dental-Medical Integration

  • Is Henry Schein (HSIC) a Solid Growth Stock? 3 Reasons to Think "Yes"

  • Henry Schein (HSIC) Upgraded to Buy: What Does It Mean for the Stock?

  • HSIC vs. MMSI: Which Stock Should Value Investors Buy Now?

  • Here's Why Henry Schein (HSIC) is a Strong Growth Stock

  • Is Henry Schein (HSIC) Stock Undervalued Right Now?

  • Henry Schein to Participate in Upcoming Investor Conferences in November and December

  • Why Henry Schein (HSIC) is a Top Value Stock for the Long-Term

  • Henry Schein, Inc. (HSIC) Q3 2026 Earnings Call Transcript

  • What Henry Schein (HSIC) Said on Its Q3 Earnings Call

  • Henry Schein Sees Pressure From Discretionary Dental Delays

  • Compared to Estimates, Henry Schein (HSIC) Q3 Earnings: A Look at Key Metrics

  • HSIC Q3 Earnings Beat, Revenues Match, '26 EPS View Up, Stock Down

  • Henry Schein (HSIC) Tops Q3 Earnings Estimates

  • Henry Schein Reports Strong 2026 Third Quarter and Raises FY2026 Guidance

  • Why Henry Schein (HSIC) is a Top Momentum Stock for the Long-Term

  • Analysts Estimate Henry Schein (HSIC) to Report a Decline in Earnings: What to Look Out for

  • Henry Schein to Report Q3 Earnings: Here's What You Should Know